Recursion Pharmaceuticals
RXRX
$8.12
Share price
3.57%
Change (1 day)
66.05%
Change (1 year)
Categories
Operating Margin for Recursion Pharmaceuticals (RXRX)
Operating Margin as of April 2024 (TTM): -542.32%
According to Recursion Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -542.32%. At the end of 2022 the company had an Operating Margin of -603.50%.
Operating Margin history for Recursion Pharmaceuticals from 2021 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -603.50% | -67.64% |
| 2021 | -1,864.79% | -26.85% |
| 2020 | -2,549.25% | -29.51% |
| 2019 | -3,616.54% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.